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ABSTRACT
Early detection of head and neck tumors is crucial for patient survival. Often, diagnoses are made based on
endoscopic examination of the larynx followed by biopsy and histological analysis, leading to a high inter-
observer variability due to subjective assessment. In this regard, early non-invasive diagnostics independent of
the clinician would be a valuable tool. A recent study has shown that hyperspectral imaging (HSI) can be used
for non-invasive detection of head and neck tumors, as precancerous or cancerous lesions show specific spectral
signatures that distinguish them from healthy tissue. However, HSI data processing is challenging due to high
spectral variations, various image interferences, and the high dimensionality of the data. Therefore, performance
of automatic HSI analysis has been limited and so far, mostly ex-vivo studies have been presented with deep
learning. In this work, we analyze deep learning techniques for in-vivo hyperspectral laryngeal cancer detection.
For this purpose we design and evaluate convolutional neural networks (CNNs) with 2D spatial or 3D spatio-
spectral convolutions combined with a state-of-the-art Densenet architecture. For evaluation, we use an in-vivo
data set with HSI of the oral cavity or oropharynx. Overall, we present multiple deep learning techniques for
in-vivo laryngeal cancer detection based on HSI and we show that jointly learning from the spatial and spectral
domain improves classification accuracy notably. Our 3D spatio-spectral Densenet achieves an average accuracy
of 81%.
Keywords: Hyperspectral imaging, convolutional neural networks, optical biopsy, intraoperative imaging, head
and neck cancer
1. INTRODUCTION
Early detection of head and neck cancer is essential for a patient’s prognosis.1 Especially, laryngeal cancer has a
high incidence, because the malignancy of lesions is often detected too late.2,3 Typically, diagnosis of malignant
tumors in the head and neck area are made based on endoscopic examination of the larynx, followed by an
invasive biopsy and histological examination, which is considered to be the gold standard. However, invasive
biopsies can lead to significant functional deterioration.4 Moreover, the prognostic quality of the diagnosis and
histological examination are strongly dependent on the experience of the clinician, thus the applied examination
methods are neither objective nor quantitative.5,6 Consequently, a non-invasive diagnostic method independent
of the clinician would be an important milestone for the detection of laryngeal cancer, greatly increasing the
chance of a successful treatment.
A recent study has shown that the diagnosis of suspicious mucosal lesions can be significantly improved by
means of extended diagnostics using optical instruments.7 The application of optical instruments for oral cancer
detection is based on the fundamental assumption that tissue characteristics change during a disease (e.g. due
to angiogenesis, increased blood circulation or inflammation) and that there are deviating absorption, scattering,
fluorescence, and metabolic properties compared to healthy tissue.8 In this regard, narrow band imaging (NBI)
in combination with induced fluorescence9 or OCT10 have been used to analyze tumor boundaries and distinguish
benign from malignant tissue.
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Moreover, hyperspectral imaging (HSI) has shown promising results for laryngeal cancer detection.11 HSI is
a noncontact imaging modality that acquires a series of images at several spectral bands, generating a hyper-
spectral image cube.12 Considering HSI for in-vivo laryngeal cancer detection, previous work has focused on
the development of an image pre-processor for HSI.13 Moreover, a previous study has shown the feasibility of
detecting laryngeal cancer based on in-vivo HSI, by using traditional machine learning algorithms.14 However,
analyzing HSI is a challenging task, because of high spectral variations, the high dimensionality of the data and
the presence of redundancy due to the high spectral resolution.12
Recently, deep learning techniques have shown promising performance for HSI with applications ranging
from agriculture, food quality to biomedicine.12 In particular, previous studies evaluated convolutional neural
networks (CNNs) for classifying head and neck cancer based on HSI of excised tissue samples, demonstrating
the potential of deep learning as a reliable ex-vivo classifier. However, an in-vivo evaluation is still missing. In
fact, in-vivo classification is particularly challenging due to image distortions, specular reflections, occlusions
and changing image quality.
Therefore, in this work we analyze deep learning techniques for in-vivo hyperspectral laryngeal tumor tissue
detection. For this purpose, we evaluate 2D spatial and 3D spatio-spectral CNNs15,16 in combination with a
state-of-the-art Densnet architecture.17 Moreover, we propose an efficient network input, based on statistical
summaries of the spectral dimension, which reduces the network complexity notably, while achieving competitive
results. For evaluation we use an in-vivo data set with HSI of the oral cavity or oropharynx of 100 patients, who
were examined due to mucous membrane abnormalities in the area of the upper aerodigestive tract. Summarized,
we demonstrate in-vivo laryngeal tumor detection using deep learning techniques and HSI.
2. METHODS AND MATERIALS
2.1 Data Set
For evaluation of our methods we use an in-vivo data set with HSI image cubes of the oral cavity or oropharynx
of patients who were examined due to mucous membrane abnormalities in the area of the upper aerodigestive
tract. The full data set consists of 100 patients and was collected at the department of otorhinolaryngology at
the university of Bonn.
Data acquisition was performed in parallel to tissue collection for diagnostic evaluation under general anaes-
thesia. In this regard, the following experimental setup was utilized. For illumination, a special Polychrome
V monochromator (TillPhotonics, Gra¨felfing, Germany) coupled to a rigid optic using a fiber optic light cable
was used. Moreover, an endoscope was fixed in an endoscope holding system (all endoscopy devices: Karl Storz
GmbH & CoKG, Tuttlingen, Germany), to minimize motion artifacts. For image acquisition a monochromatic
CCD-camera (AxioCamMRm, Carl Zeiss Microimaging GmbH, Go¨ttingen, Germany) was used. The camera
was coupled to the endoscope using a dedicated C-mount coupler. For each subject, the field of interest of the
mucosa was focused during data acquisition and a HS cube was generated with a spectral range from 380 nm
to 680 nm in 30 iterative steps of 10 nm. Images were acquired with a spatial camera resolution of 1040× 1388
pixels. This study was approved by the local ethics committee (# 176/10 & 061/13, University of Bonn).
For data labelling, clinically healthy areas and clinically suspect areas were marked in the recorded images
by medical experts. Next, the clinically suspect areas were histopathologically confirmed. For the healthy areas,
no tissue extraction was performed, due to ethical reasons. The following Figure 1 shows example images with
the marked areas. In this work we focus on classifying the marked areas to obtain a well-defined ground truth.
While all images contain a marked suspect area, not all contain a marked healthy area. In particular, out of the
100 subjects, 70 subjects have both areas marked and 30 only have a suspect area marked.
Before applying our deep learning methods, we used the following preprocesisng pipeline. First, hyperspectal
image stacks were aligend using the ImageJ-implementation of the SIFT-algorithm Linear Stack Alignment
with SIFT.18 Next, the HSI cubes were filtered using the minimum noise fraction (MNF)19 transformation, as
recommended in a previous study on preprocessing of operational HSI of the head and neck area.13
To evaluate and train our CNNs, we crop sub-images with a size of 32× 32 pixels out of the marked areas of
the full image. These image crops serve as the input for our CNNs. Note, some pixel regions of the marked areas
show extreme specular reflections, which are based on wet surfaces completely reflecting incident light. For this
purpose, we excluded image crops, which contain regions with extreme specular reflections, by filtering with an
intensity threshold.
Figure 1. Example images of the laryngeal cancer data set shown as an RGB image derived from the HSI cube. The green
area segments a region, which is labeled as tumor tissue. The black area refers to a region, which is labeled as healthy
tissue.
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Figure 2. Our baseline architecture with three Densenet-Blocks and a global average pooling (GAP) layer before the
output layer. The architecture receives a subimage x cropped from the full HSI cube to detect tumor or healthy tissue.
2.2 Deep Learning Methods
Models. To detect laryngeal tumor tissue our deep learning models receive image crops with a size of 32×32×30
(high-width-spectral dimensions), cropped from the marked areas of the images, together with the corresponding
label of tumor or healthy tissue. As a baseline architecture for our CNNs we adopt the idea of of densely
connected neural networks (Densenet).17 We use one initial convolutional layer, followed by three Densenet-
Blocks, which are connected with transition layers. Before the classification layer we use a global average pooling
layer (GAP). The architecture is shown in Figure 2. For this baseline architecture we evaluate and compare
three different methods to learn from the HSI data, shown in Figure 3. Hyperparameters are tuned individually
for each network.
First, we use 2D spatial convolutions and stack all spectral dimensions into the input’s channel dimension.15
Hence, the input of our network (Densenet2D) is 32 × 32 × 30. Note, 2D convolutions only convolute over the
spatial dimensions, thus the spectral dimension is only processed as channel dimension.
Second, we use 2D spatial convolutions and we statically summarize the spectral dimension for each pixel. For
this purpose, we estimate the pixel-wise mean and standard deviation, thus we obtain one image with mean pixel
intensities and one image with the standard deviation of the pixel intensities, which we stack into the input’s
channel dimension.20 Consequently, the input of our network (Densenet2D-MS) is 32× 32× 2.
Third, we jointly learn from the spectral and spatial dimension by employing 3D convolutions.16 Thus, the input
of our network (Densenet3D) is 32× 32× 30× 1.
Training and Evaluation. Due to the small data set size, we use 8-fold cross-validation. For each fold, we
equally split the data into a test and validation subset. Subsequently, we leverage the validation subset for
hyperparameter tuning. For reporting test performances, we average the metrics over all test folds. For data
augmentation we use random cropping and random flipping during training. To evaluate the performance for
a marked area, we use ordered crops and the predictions of all crops are averaged to obtain one classification.
We train our models for 300 iterations with a batch size of 20 and Adam for optimization. To counter the class
imbalance, we weight the loss of the individual classes inversely proportional to samples of each class.
Table 1. Results for all experiments. Sensitivity and specificity are reported with respect to classifying an image as tumor
tissue.
Accuracy Sensitivity Specificity F1-Score
Densenet2D 0.64± 0.13 0.69± 0.19 0.62± 0.41 0.67± 0.12
Densenet2D-MS 0.75± 0.13 0.90± 0.08 0.54± 0.24 0.76± 0.11
Densenet3D 0.81± 0.09 0.92± 0.12 0.65± 0.21 0.82± 0.09
x ∈ R
32×32×30
mean/std
xMS ∈ R
32×32×2
x ∈ R
32×32×30
x ∈ R
32×32×30×1
Densenet3D
(conv3d)
Densenet2D-MS
(conv2d)
Densenet2D
(conv2d)
Figure 3. Combined with our baseline architecture we evaluate three different methods to learn from the subimages x,
which are cropped from the full HSI cube. (Left) Using 2D convolutions with the input’s channel dimension as spectral
dimension. (Middle) Employing 2D convolutions and using the pixel-wise mean and standard deviation as input. (Right)
Using 3D spatio-spectral convolutions and treating the data as three dimensional.
3. RESULTS
The results of all our experiments are shown in Table 1. We consider accuracy, sensitivity, specificity and the
F1-Score. For each metric, we report the mean and standard deviation averaged over all cross-validation folds.
Densenet3D performs best with a high sensitivity and specificity, followed by Densenet2D-MS. Across all metrics
Densenet2D shows the worst performance. In addition, Figure 4 shows the receiver operating characteristic
(ROC) for the different methods. In this regard, Densenet3D and Densenet2D-MS perform similar for low false
positive rates. However, overall Densenet3D clearly shows the best performance.
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Figure 4. ROC curve for the different models shown for the detection of laryngeal tumor tissue.
4. DISCUSSION AND CONCLUSION
We study deep learning methods for in-vivo detection of laryngeal tumor tissue using HSI. Automatic decision
support independent of the clinician could greatly increase the chance of an early detection and a successful
treatment. For this purpose we investigate the use of CNNs for in-vivo HSI.
Considering a data set of 100 patients and applying 8-fold cross validation, our architecture with 3D convo-
lutions (Densenet3D) performs best with an mean F1-Score of 82%. Moreover, our method Densenet3D achieves
a high mean sensitivity of 92%, while also having a good specficicity of 65%. This fits the requirements of a
clinical decision support system, which needs a high sensitivity to detect all tumors. In fact, considering the
limited training data and the challenges associated with in-vivo classification, our results are promising.
Using 2D CNNs and using the input’s channel as the spectral dimension turned out to be ineffective. This
demonstrates that the 2D CNN does not generalize well if all the potentially redundant spectral information is
stacked into the channel dimension. Instead, our method with 2D convolutions and using the mean and standard
deviation of the pixel intensities along the spectral dimension turned out to be effective. This indicates that
reducing the spectral dimension is beneficial for processing with a 2D CNN.
Moreover, all metrics show a relatively large standard deviation, which is caused by variations across patients.
This can be explained by the heterogeneity of the in-vivo data set where different view-points, light intensities,
or occlusions are present. Thus, robust and generalizable deep learning model development is a challenging task
that needs to be solved for automatic clinical decision support with HSI.
In general, our methods have the advantage that once a network is trained, it does not require excised tissue
samples and purely operates as an optical assessment method based on HSI. We achieve a high performance on
a challenging in-vivo dataset which is a promising advancement towards clinical decision support for laryngeal
tumor detection. In conclusion, we demonstrate the ability of deep learning methods to detect laryngeal tumor
tissue based on in-vivo HSI. Future work could also focus on differentiating between precancerous and cancerous
lesions, and segmenting tumor boundaries based on in-vivo HSI.
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